C
CBR is dedicated to advancing the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials, exclusive to CBR families, for conditions that have no cure today. This is only made possible by CBR's relentless pursuit of product quality. That's why more families choose CBR. We have stored over 900,000 cord blood and cord tissue stem cell units and are the #1 recommended cord blood company by OB/GYNs and expecting parents. CBR is hiring! Visit the Careers page at cordblood.com for employment opportunities.
Investor insights
Funding rounds participated in
$18M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
1995
Funding rounds raised
Total raised
$18M
from 1 investors over 1 rounds
C
Cord Blood Registry raised $18M on November 15, 2002
Investors: ABS Capital Partners